List Price: $219
Credits: 7.0 CMLE
Course Director:
Irma Pereira, MT(ASCP)SH
Clinical Hematology Specialist and Consultant, Clinical Hematology
Adjunct Lecturer in Hematology, Department of Medicine, Stanford University Hospital, Stanford, CA

Although this workshop is Part I of two sessions, each may be taken separately. Part II will be presented on May 15.

Enhance your productivity in hematology and gain confidence in your ability to evaluate a peripheral smear, especially when faced with a patient with an undiagnosed hematologic disorder. Diagnostic ability is essential to the proper evaluation of a patient’s hematological status. Erroneous or inaccurate results can lead to an incorrect diagnosis, causing delayed or inappropriate treatment. Yet each day, you are called upon to analyze cell morphology on peripheral smears without the benefit of a case history, in a rather “blind study” fashion. Attend this intermediate-level workshop to increase your hematological acuity and gain self-assurance in your morphology and diagnostic skills!

In Part I, more than four hundred images will be used to demonstrate techniques for the peripheral smear diagnosis of myeloproliferative disorders. In addition, differential diagnosis exercises, using only peripheral smear findings, will challenge your knowledge and reinforce the information presented.

You will hear in-depth presentations on:

• Chronic Myeloproliferative Disorders (CML, PV, CIMF, ET, CNL) and early transformation recognition
• Myelodysplastic Syndromes and the CMPD/MDS Syndromes (CMML, JMML, aCML)
• WHO classification of the myelodysplastic disorders (RA, RARS, RAMLD, RAEB [types l and ll] and 5q^- Syndrome)
• Acute Myeloid Leukemias according to WHO Classification, including the new sub classifications vs. the renamed FAB classification (AML NOS)
• Granulocyte dysfunction syndromes

Following this workshop, you will be able to:

• Apply improved morphologic skills to more accurate diagnoses of hematologic problems
• Assist non-hematologist physicians in understanding patient disorders
• Alert physicians to unknown hematologic situations
• Discuss patient diagnoses at a higher technical level